Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/labinvest.2017.81 http://scihub22266oqcxt.onion/10.1038/labinvest.2017.81 C5918271!5918271!28759008     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Lab+Invest 2017 ; 97 (10): 1126-32 Nephropedia Template TP {{tp|p=28759008|t=2017. A pathologist?s perspective on induced pluripotent stem cells |pdf=|usr=}}{{28759008}} gab.com Text A pathologist s perspective on induced pluripotent stem cells JO: Lab Invest http://www.kidney.de/pget.php?&tw=1&pmid=28759008 #FOAvip Induced pluripotent stem cell (iPSC) technology was originally developed in 2006. Essentially, it converts somatic cells into pluripotent stem cells by transiently expressing a few transcriptional factors. Once generated, these iPSCs can differentiate into all the cell types of our body, theoretically, which has attracted great attention for clinical research including disease pathobiology studies. Could this technology then become an additional research or diagnostic tool widely available to practicing pathologists? Here we summarize progress in iPSC research toward disease pathobiology studies, its future potential, and remaining problems from a pathologist?s perspective. A particular focus will be on introducing the effort to recapitulate disease-related morphological changes through three-dimensional culture of stem cells such as organoid differentiation. Twit Text FOAVip A pathologist s perspective on induced pluripotent stem cells ????Lab Invest http://www.kidney.de/pget.php?&tw=1&pmid=28759008 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28759008 #FOAvip English Wikipedia <ref>{{Cite pmid|28759008}}</ref> A pathologist?s perspective on induced pluripotent stem cells #MMPMID28759008 Watanabe N; Santostefano KE; Yachnis AT; Terada N Lab Invest 2017[Oct]; 97 (10): 1126-32 PMID28759008show ga Induced pluripotent stem cell (iPSC) technology was originally developed in 2006. Essentially, it converts somatic cells into pluripotent stem cells by transiently expressing a few transcriptional factors. Once generated, these iPSCs can differentiate into all the cell types of our body, theoretically, which has attracted great attention for clinical research including disease pathobiology studies. Could this technology then become an additional research or diagnostic tool widely available to practicing pathologists? Here we summarize progress in iPSC research toward disease pathobiology studies, its future potential, and remaining problems from a pathologist?s perspective. A particular focus will be on introducing the effort to recapitulate disease-related morphological changes through three-dimensional culture of stem cells such as organoid differentiation. äA pathologist?s perspective on induced pluripotent stem cells (epmc).pdf DeepDyve Pubget Overpricing